Tackling the Rotation Dilemma

 | May 07, 2013 | 6:53 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

aa

,

vale

,

clf

,

bmy

,

amgn

One minute you can't own enough drug stocks. The next minute you can't own any drug stocks. Same with the foods. But where to go?

Do you go to the worst, knowing they can only get better? Or do you go to the good, knowing that they are good?

I have been in this dilemma many times in my life and I have always resolved it in a practical, but chicken, way: pick the worst who have already told you things are bad. That way you won't be shocked when they stay bad.

Along these lines you can make a case for Cliffs Natural (CLF), Vale (VALE) and Alcoa (AA). Cliffs Natural and Vale are iron-ore plays and nothing's more in glut in iron ore than aluminum, hence Alcoa. Here are three companies that are still being shorted, still being bet against with everyone writing them off. Vale, no matter what it does, is known as one of the absolute favorite hedge fund shorts because of its relationship with China. The shorts don't care about the yield, they think the dividend's a goner even if it was just declared.

Alcoa? The rap here is that it needs to do an equity offering to satisfy the ratings agencies. No matter that it is closing expensive capacity in Europe and building cheap capacity here. The company's extremely well run, but it doesn't matter as long as aluminum is in glut. But take a look when it wasn't in 2007. You get a five-fold hit.

Cliffs is the most difficult of all. First, its balance sheet is improved ever since it did what, in retrospect, was a brilliant deal offering stock at $29. Unfortunately, everyone who bought in on it was crushed, something I know I didn't see coming. Second, not that long after, a major brokerage said that  Cliffs is about to fall victim to a major expansion of iron ore sales in this country, which sounds suspiciously like what happened to the old Cleveland Cliffs when there was too much iron ore. So, it became a free-fire zone.

What do you do? Alcoa's a call already, by virtue of its $8 stock. Vale can be done in Sept. 15 calls for a couple of bucks and Cliffs October 15s for 6 and change.

You want to match it with something on the other side? Neither Bristol-Myers (BMY) nor Amgen (AMGN) had the growth I expected. Puts could be in order.

Now, I am reluctant to short anything here because the sector rotations are very swift. But a long call/common CLF, Vale, AA, long put Amgen, BMY (preferable the in-the-monies) might be the way to play this next leg.

Columnist Conversations

GLD for the past 5 years to today is +18%. GDX for the past 5 years to today is -50%. that's quite a eye-poppi...
This morning's Markit Manufacturing PMI figures out of Europe offer a mixed bag, but there were two disappoint...
1100 Handle May be Around the Corner
The action in the DOW today was the reverse of what we saw yesterday in the index. The rally off the lows in t...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.